On September 30, Lukang Pharmaceutical stated on an interactive platform that the company's products are exported to more than 80 countries and regions, covering penicillin series, cephalosporin series, tylosomycin series, and hypoglycemic and lipid-lowering products. Currently, the company's production and sales are normal, and the market is stable.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.